Infections averted by a comprehensive HIV prevention intervention and its cost-effectiveness : a prospective cohort study of persons who inject drugs in Delhi, India / Lopamudra Ray Saraswati, Aparajita Dasgupta, Indrani Gupta, Julie Pulerwitz & Avina Sarna
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Journal of development effectiveness - 15(2023), 1, Seite 77-90 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Saraswati, Lopamudra Ray [VerfasserIn] |
|---|
| Links: |
doi.org [lizenzpflichtig] |
|---|
| Themen: |
Öffentliche Ausgaben |
|---|
| doi: |
10.1080/19439342.2023.2166565 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1844767647 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | 1844767647 | ||
| 003 | DE-627 | ||
| 005 | 20230511133553.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230508s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/19439342.2023.2166565 |2 doi | |
| 035 | |a (DE-627)1844767647 | ||
| 035 | |a (DE-599)KXP1844767647 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a RI01.13 |2 fivr | ||
| 084 | |a SG03.02 |2 fivs | ||
| 100 | 1 | |a Saraswati, Lopamudra Ray |e verfasserin |0 (DE-588)128862199X |0 (DE-627)1844767175 |4 aut | |
| 245 | 1 | 0 | |a Infections averted by a comprehensive HIV prevention intervention and its cost-effectiveness |b a prospective cohort study of persons who inject drugs in Delhi, India |c Lopamudra Ray Saraswati, Aparajita Dasgupta, Indrani Gupta, Julie Pulerwitz & Avina Sarna |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 650 | 0 | 7 | |0 (DE-588)4048390-3 |0 (DE-627)104106689 |0 (DE-576)209077581 |a Randgruppe |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4138597-4 |0 (DE-627)104577576 |0 (DE-576)209687398 |a Drogenabhängigkeit |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4198658-1 |0 (DE-627)105187038 |0 (DE-576)210123443 |a Drogenkonsum |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4026879-2 |0 (DE-627)104288914 |0 (DE-576)208968350 |a Infektionskrankheit |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4112470-4 |0 (DE-627)105836931 |0 (DE-576)209468262 |a Aids |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4203852-2 |0 (DE-627)105147915 |0 (DE-576)210157976 |a HIV-Infektion |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4136584-7 |0 (DE-627)104331119 |0 (DE-576)209670436 |a Gesundheitsvorsorge |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4043136-8 |0 (DE-627)106210971 |0 (DE-576)209054441 |a Öffentliche Ausgaben |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4020754-7 |0 (DE-627)104658827 |0 (DE-576)208934650 |a Gesundheit |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4134963-5 |0 (DE-627)105668664 |0 (DE-576)209656735 |a Aufwendung |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)4032579-9 |0 (DE-627)106261193 |0 (DE-576)20899758X |a Kosten |2 gnd |
| 650 | 0 | 7 | |0 (DE-588)7859045-0 |0 (DE-627)700633154 |0 (DE-576)361772335 |a Effektivität |2 gnd |
| 651 | 7 | |0 (DE-588)4026722-2 |0 (DE-627)104585129 |0 (DE-576)208967699 |a Indien |2 gnd | |
| 700 | 1 | |a Dasgupta, Aparajita |e verfasserin |0 (DE-588)1280835869 |0 (DE-627)1834613361 |4 aut | |
| 700 | 1 | |a Gupta, Indrani |e verfasserin |0 (DE-588)1075059720 |0 (DE-627)832910104 |0 (DE-576)443233845 |4 aut | |
| 700 | 1 | |a Pulerwitz, Judie |e verfasserin |4 aut | |
| 700 | 1 | |a Sarna, Avina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of development effectiveness |d London [u.a.] : Routledge, Taylor & Francis Group, 2009 |g 15(2023), 1, Seite 77-90 |h Online-Ressource |w (DE-627)603487610 |w (DE-600)2501689-1 |w (DE-576)308344979 |x 1943-9407 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:1 |g pages:77-90 |
| 856 | 4 | 0 | |u https://doi.org/10.1080/19439342.2023.2166565 |x Resolving-System |z lizenzpflichtig |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_2470 | ||
| 912 | |a ISIL_DE-615 | ||
| 912 | |a ISIL_DE-B1503 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_63 | ||
| 912 | |a GBV_ILN_65 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_151 | ||
| 912 | |a GBV_ILN_224 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_370 | ||
| 912 | |a GBV_ILN_647 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2007 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2025 | ||
| 912 | |a GBV_ILN_2026 | ||
| 912 | |a GBV_ILN_2034 | ||
| 912 | |a GBV_ILN_2055 | ||
| 912 | |a GBV_ILN_2088 | ||
| 912 | |a GBV_ILN_2093 | ||
| 912 | |a GBV_ILN_2111 | ||
| 912 | |a GBV_ILN_2336 | ||
| 912 | |a GBV_ILN_2507 | ||
| 912 | |a GBV_ILN_2548 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4246 | ||
| 912 | |a GBV_ILN_4249 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4313 | ||
| 912 | |a GBV_ILN_4393 | ||
| 912 | |a GBV_ILN_4700 | ||
| 936 | f | i | |0 (DE-627)1756133980 |a RI01.13 |b Indien |k Asien (ohne westliches Asien) |k Südasien |k Indien |2 fivr |
| 936 | f | i | |0 (DE-627)1756136017 |a SG03.02 |b Gesundheit |k Gesellschaft |k Sozialpolitik/Soziales |k Gesundheit |2 fivs |
| 936 | u | w | |d 15 |j 2023 |e 1 |h 77-90 |
| 938 | 1 | 0 | |0 (DE-627)1756220948 |0 (DE-615)6601590 |a Indien |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)175618612X |0 (DE-615)6610230 |a Soziale Randgruppe |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756197660 |0 (DE-615)6600831 |a Drogenabhängigkeit/Drogenkonsum |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756179646 |0 (DE-615)6604621 |a Infektionskrankheit |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)175617766X |0 (DE-615)6608656 |a HIV/AIDS |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756213933 |0 (DE-615)6610302 |a Gesundheitsvorsorge |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756157138 |0 (DE-615)6606158 |a Öffentliche Ausgaben für Gesundheit |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756162638 |0 (DE-615)6602081 |a Kosten/Aufwand |2 fivt |
| 938 | 1 | 0 | |0 (DE-627)1756166420 |0 (DE-615)6602637 |a Effizienz/Effektivität |2 fivt |
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 1 |h 77-90 | ||
| 980 | |2 2470 |1 01 |x DE-615 |b 4319143809 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 08-05-23 | ||
| 980 | |2 2470 |1 02 |x DE-B1503 |b 4320121600 |c 00 |f --%%-- |d --%%-- |e --%%-- |j l |y l02 |z 09-05-23 | ||
| 998 | |2 2470 |1 01 |x DE-615 |0 2023-05-08 | ||